JP2004502773A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502773A5
JP2004502773A5 JP2002509312A JP2002509312A JP2004502773A5 JP 2004502773 A5 JP2004502773 A5 JP 2004502773A5 JP 2002509312 A JP2002509312 A JP 2002509312A JP 2002509312 A JP2002509312 A JP 2002509312A JP 2004502773 A5 JP2004502773 A5 JP 2004502773A5
Authority
JP
Japan
Prior art keywords
group
compound
formula
aryl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002509312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502773A (ja
Filing date
Publication date
Priority claimed from GB0017055A external-priority patent/GB0017055D0/en
Priority claimed from GB0030689A external-priority patent/GB0030689D0/en
Application filed filed Critical
Priority claimed from PCT/GB2001/003111 external-priority patent/WO2002004447A1/en
Publication of JP2004502773A publication Critical patent/JP2004502773A/ja
Publication of JP2004502773A5 publication Critical patent/JP2004502773A5/ja
Pending legal-status Critical Current

Links

JP2002509312A 2000-07-11 2001-07-11 抗癌剤としてのバリオリン誘導体 Pending JP2004502773A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0017055A GB0017055D0 (en) 2000-07-11 2000-07-11 Synthesis
GB0030689A GB0030689D0 (en) 2000-12-15 2000-12-15 Synthesis
PCT/GB2001/003111 WO2002004447A1 (en) 2000-07-11 2001-07-11 Variolin derivatives as anti-cancer agents

Publications (2)

Publication Number Publication Date
JP2004502773A JP2004502773A (ja) 2004-01-29
JP2004502773A5 true JP2004502773A5 (https=) 2008-08-28

Family

ID=26244637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002509312A Pending JP2004502773A (ja) 2000-07-11 2001-07-11 抗癌剤としてのバリオリン誘導体

Country Status (20)

Country Link
US (1) US7320981B2 (https=)
EP (1) EP1299388B1 (https=)
JP (1) JP2004502773A (https=)
KR (1) KR100886161B1 (https=)
CN (1) CN1324028C (https=)
AT (1) ATE431349T1 (https=)
AU (3) AU2001270783B2 (https=)
BR (1) BR0112413A (https=)
CA (1) CA2414200C (https=)
CY (1) CY1109283T1 (https=)
DE (1) DE60138707D1 (https=)
DK (1) DK1299388T3 (https=)
ES (1) ES2327210T3 (https=)
IL (2) IL153682A0 (https=)
MX (1) MXPA03000341A (https=)
NZ (1) NZ523491A (https=)
PT (1) PT1299388E (https=)
RU (1) RU2299884C2 (https=)
SI (1) SI1299388T1 (https=)
WO (1) WO2002004447A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) * 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds
MXPA05012377A (es) 2003-05-15 2006-05-25 Arqule Inc Derivados de imidazotiazoles e imidazoxazol como inhibidores de p38.
WO2006010082A1 (en) 2004-07-08 2006-01-26 Arqule, Inc. 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
JP2008517064A (ja) 2004-10-19 2008-05-22 アークル インコーポレイテッド Ｐ３８ｍａｐキナーゼのイミダゾオキサゾールおよびイミダゾチアゾール阻害剤の合成
EP1666467A1 (en) * 2004-11-08 2006-06-07 Evotec AG 11Beta-HSD1 Inhibitors
WO2006075591A1 (ja) * 2005-01-12 2006-07-20 Kuraray Co., Ltd. 樹脂組成物及びそれからなるフィルム
DE602006014540D1 (en) * 2005-05-16 2010-07-08 Irm Llc Pyrrolopyridinderivate als proteinkinaseinhibitoren
HRP20231233T1 (hr) 2017-04-27 2024-01-19 Pharma Mar, S.A. Antitumorski spojevi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI944602A0 (fi) * 1992-04-03 1994-10-03 Upjohn Co Farmaseuttisesti aktiiviset bisyklis-heterosykliset amiinit
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds

Similar Documents

Publication Publication Date Title
MXPA04000677A (es) Tienopirimidindionas y su uso en modulacion de enfermedades autoinmunes.
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
ATE123771T1 (de) Stickstoff enthaltende heterozyklische verbindungen, ihre herstellung und verwendung.
JP2008526999A5 (https=)
ATE313535T1 (de) Pyrazinyl-piperazin-verbindungen, ihre anwendung und herstellung
JP2005519932A5 (https=)
EP1829858A3 (en) Dibenzylamine compounds and pharmaceutical use thereof
MY136270A (en) Processes and intermediates for preparing anti-cancer compounds
JP2005514398A5 (https=)
SE0001438D0 (sv) New chemical compounds and their use in therapy
NZ515282A (en) Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
SG166678A1 (en) Synthesis of 4amino-2-butenoyl cholrides and their use in the preparation of 3-cyano quinolines
NZ307505A (en) Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2004502773A5 (https=)
JO2413B1 (en) Benzoxazine derivatives and their use
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
JP2009520695A5 (https=)
RU2003103856A (ru) Производные вариолина, способы их получения и применение указанных веществ в качестве противораковых средств
CA2395969A1 (en) Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them
ZA200704584B (en) New 3-Phenylpropionic acid derivatives for the treatment of diabetes
JP2010505759A5 (https=)
CA2414200A1 (en) Variolin derivatives as anti-cancer agents
WO2005080368A3 (en) Benzopyran compound useful for the treatment of arrhytmia